<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="11">
  <stage>Registered</stage>
  <submitdate>12/07/2005</submitdate>
  <approvaldate>18/07/2005</approvaldate>
  <actrnumber>ACTRN12605000022662</actrnumber>
  <trial_identification>
    <studytitle>Glucose normalization Effects on Echo and Novel vascular markers in Acute myocardial infarction</studytitle>
    <scientifictitle>Impact of tight glycaemic control with insulin on novel vascular markers and myocardial function and perfusion in acute myocardial infarction patients with hyperglycaemia</scientifictitle>
    <utrn />
    <trialacronym>GEENA</trialacronym>
  </trial_identification>
  <conditions>
    <healthcondition>Hyperglycaemia post non ST elevation myocardial infarction.</healthcondition>
    <conditioncode>
      <conditioncode1>Cardiovascular</conditioncode1>
      <conditioncode2>Other cardiovascular diseases</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Blood</conditioncode1>
      <conditioncode2>Other blood disorders</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>"Intensive treatment" (intravenous insulin infusion for 24 hours followed by tight glycaemic control aiming BGL 4.5 - 7mmol/L throughout admission).</interventions>
    <comparator>"Standard treatment" (Aiming for BGL 6 - 12mmol/L throughout admission without the use of an insulin infusion).</comparator>
    <control>Placebo</control>
    <interventioncode>None</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Differences in the change in wall motion score index (by contrast echocardiography) between admission, day 3-5 and after 3 months.</outcome>
      <timepoint>Between admission, day 3-5 and after 3 months</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Changes in inflammatory markers</outcome>
      <timepoint>At admission, day 1, day 3-5 and 3 months.</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Changes in myocardial perfusion</outcome>
      <timepoint>From admission to day 3-5 and 3 months.</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Non ST Non ST elevation myocardial infarct within 24 hoursBGL &gt;=10mmol/Lelevation myocardial infarct within 24 hoursBGL &gt;=10mmol/L</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>Not stated</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Current infection; Active inflammatory conditions; Women of child bearing potential; Known cardiac shuntInsulin allergy.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment />
    <sequence>Balanced randomisation will be performed using permuted blocks based upon 3 stratification variables at baseline (eg 8 possible strata): (1) age &gt;=65 years (2) ejection fraction &gt;grade 2  (3)diabetes. Random binary digit sequences will be generated using Stata statistical software.</sequence>
    <masking>Open (masking not used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase />
    <anticipatedstartdate>10/10/2005</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>40</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Not yet recruiting</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>Government body</primarysponsortype>
    <primarysponsorname>Melbourne Health</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Commercial sector/Industry</fundingtype>
      <fundingname>Bristol-Myers-Squibb Medical Imaging Physician Initiated Clinical Research Grant</fundingname>
      <fundingaddress />
      <fundingcountry />
    </fundingsource>
    <fundingsource>
      <fundingtype>Government body</fundingtype>
      <fundingname>NHMRC post-graduate scholarship</fundingname>
      <fundingaddress />
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname>Nil</sponsorname>
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary />
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Dr Leo Rando</name>
      <address>Department of Diabetes and Endocrinology
The Royal Melbourne Hospital
Grattan St
Parkville VIC 3050</address>
      <phone>+61 3 93427365</phone>
      <fax />
      <email>leo.rando@mh.org.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Dr Angela Watt</name>
      <address>Research Directorate
Melbourne Health
The Royal Melbourne Hospital
Grattan St
Parkville VIC 3050</address>
      <phone>+61 3 93427550</phone>
      <fax />
      <email>angela.watt@mh.org.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>